PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jmedgeneJournal of Medical GeneticsVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
 
J Med Genet. 1999 October; 36(10): 767–770.
PMCID: PMC1734234

Microdeletions in FMR2 may be a significant cause of premature ovarian failure

Abstract

Genetic causes of premature ovarian failure (POF) include X chromosome deletions and fragile X (FRAXA) premutations. While screening a cohort of women with POF for FRAXA premutations, a more distal trinucleotide repeat, FRAXE, was also tested. We found an unexpected excess of FRAXE alleles with apparently fewer than 11 repeats in the POF group. However, sequence analysis of these alleles showed that the excess was caused by three females who carry cryptic deletions in FMR2, the gene associated with FRAXE. We propose that microdeletions within FMR2 may be a significant cause of premature ovarian failure, being found in 1.5% of women with the condition, and in only 0.04% of the general female population. The deletions may affect transcription of either FMR2 or an adjacent gene.


Keywords: FMR2; deletion; premature ovarian failure

Full Text

The Full Text of this article is available as a PDF (77K).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Knight SJ, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, Phelps SR, Pointon J, Middleton-Price HR, Barnicoat A, Pembrey ME, et al. Trinucleotide repeat amplification and hypermethylation of a CpG island in FRAXE mental retardation. Cell. 1993 Jul 16;74(1):127–134. [PubMed]
  • Zhong N, Ju W, Curley D, Wang D, Pietrofesa J, Wu G, Shen Y, Pang C, Poon P, Liu X, et al. A survey of FRAXE allele sizes in three populations. Am J Med Genet. 1996 Aug 9;64(2):415–419. [PubMed]
  • Hamel BC, Smits AP, de Graaff E, Smeets DF, Schoute F, Eussen BH, Knight SJ, Davies KE, Assman-Hulsmans CF, Oostra BA. Segregation of FRAXE in a large family: clinical, psychometric, cytogenetic, and molecular data. Am J Hum Genet. 1994 Nov;55(5):923–931. [PubMed]
  • Mulley JC, Yu S, Loesch DZ, Hay DA, Donnelly A, Gedeon AK, Carbonell P, López I, Glover G, Gabarrón I, et al. FRAXE and mental retardation. J Med Genet. 1995 Mar;32(3):162–169. [PMC free article] [PubMed]
  • Barnicoat AJ, Wang Q, Turk J, Green E, Mathew CG, Flynn G, Buckle V, Hirst M, Davies K, Bobrow M. Clinical, cytogenetic, and molecular analysis of three families with FRAXE. J Med Genet. 1997 Jan;34(1):13–17. [PMC free article] [PubMed]
  • Gecz J, Gedeon AK, Sutherland GR, Mulley JC. Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet. 1996 May;13(1):105–108. [PubMed]
  • Gu Y, Shen Y, Gibbs RA, Nelson DL. Identification of FMR2, a novel gene associated with the FRAXE CCG repeat and CpG island. Nat Genet. 1996 May;13(1):109–113. [PubMed]
  • Gecz J, Bielby S, Sutherland GR, Mulley JC. Gene structure and subcellular localization of FMR2, a member of a new family of putative transcription activators. Genomics. 1997 Sep 1;44(2):201–213. [PubMed]
  • Gedeon AK, Meinänen M, Adès LC, Käriäinen H, Gécz J, Baker E, Sutherland GR, Mulley JC. Overlapping submicroscopic deletions in Xq28 in two unrelated boys with developmental disorders: identification of a gene near FRAXE. Am J Hum Genet. 1995 Apr;56(4):907–914. [PubMed]
  • Holden JJ, Julien-Inalsingh C, Chalifoux M, Wing M, Scott E, Fidler K, Swift I, Maidment B, Knight SJ, Davies KE, et al. Trinucleotide repeat expansion in the FRAXE locus is not common among institutionalized individuals with non-specific developmental disabilities. Am J Med Genet. 1996 Aug 9;64(2):420–423. [PubMed]
  • Brown TC, Tarleton JC, Go RC, Longshore JW, Descartes M. Instability of the FMR2 trinucleotide repeat region associated with expanded FMR1 alleles. Am J Med Genet. 1997 Dec 31;73(4):447–455. [PubMed]
  • Coulam CB, Adamson SC, Annegers JF. Incidence of premature ovarian failure. Obstet Gynecol. 1986 Apr;67(4):604–606. [PubMed]
  • Conway GS, Payne NN, Webb J, Murray A, Jacobs PA. Fragile X premutation screening in women with premature ovarian failure. Hum Reprod. 1998 May;13(5):1184–1187. [PubMed]
  • Murray A, Webb J, Grimley S, Conway G, Jacobs P. Studies of FRAXA and FRAXE in women with premature ovarian failure. J Med Genet. 1998 Aug;35(8):637–640. [PMC free article] [PubMed]
  • Murray A, Youings S, Dennis N, Latsky L, Linehan P, McKechnie N, Macpherson J, Pound M, Jacobs P. Population screening at the FRAXA and FRAXE loci: molecular analyses of boys with learning difficulties and their mothers. Hum Mol Genet. 1996 Jun;5(6):727–735. [PubMed]
  • Richards RI, Crawford J, Narahara K, Mangelsdorf M, Friend K, Staples A, Denton M, Easteal S, Hori TA, Kondo I, et al. Dynamic mutation loci: allele distributions in different populations. Ann Hum Genet. 1996 Sep;60(Pt 5):391–400. [PubMed]
  • Thacker J, Chalk J, Ganesh A, North P. A mechanism for deletion formation in DNA by human cell extracts: the involvement of short sequence repeats. Nucleic Acids Res. 1992 Dec 11;20(23):6183–6188. [PMC free article] [PubMed]
  • Allingham-Hawkins DJ, Babul-Hirji R, Chitayat D, Holden JJ, Yang KT, Lee C, Hudson R, Gorwill H, Nolin SL, Glicksman A, et al. Fragile X premutation is a significant risk factor for premature ovarian failure: the International Collaborative POF in Fragile X study--preliminary data. Am J Med Genet. 1999 Apr 2;83(4):322–325. [PubMed]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Group